Market Cap (In CNY)
6.78 Billion
Revenue (In CNY)
1.06 Billion
Net Income (In CNY)
395.93 Million
Avg. Volume
1.38 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.0-20.61
- PE
- -
- EPS
- -
- Beta Value
- 0.675
- ISIN
- CNE1000042Q8
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Mulin Chen
- Employee Count
- -
- Website
- https://www.kqbio.com
- Ipo Date
- 2020-09-22
- Details
- Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was founded in 2001 and is based in Wuhan, China.
More Stocks
-
000695
-
MARI
-
SMFIL
-
EAWD
-
FJTSFFujitsu Limited
FJTSF
-
SHECF
-
KARNKardex Holding AG
KARN
-
SEFERSergeFerrari Group SA
SEFER